{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T12:47:39Z","timestamp":1792673259755,"version":"4.5.0"},"reference-count":245,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:00:00Z","timestamp":1792022400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion Clinique et Biologique"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.tracli.2026.08.003","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T14:57:25Z","timestamp":1787669845000},"page":"271-293","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Recommandations pour le suivi immuno-h\u00e9matologique (IH) de la femme enceinte. Groupe de travail\u00a0: allo-immunisation f\u0153to-maternelle anti-\u00e9rythrocytaire de la Soci\u00e9t\u00e9 francophone de transfusion sanguine"],"prefix":"10.1016","volume":"33","author":[{"given":"C\u00e9cile","family":"Toly-Ndour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elodie","family":"Piccione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Magdelaine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aline","family":"Floch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Vinatier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Marc","family":"Minon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gauthier","family":"Alluin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuelle","family":"Guinchard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Delugin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Kimmel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Rati\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Luce","family":"Boennec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Petit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Oubouzar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurine","family":"Laget","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muriel","family":"Bouton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Djamel","family":"Bakour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9n\u00e9dicte","family":"Debiol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Said","family":"Amrouche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Cortey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agn\u00e8s","family":"Mailloux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tracli.2026.08.003_bib1000","series-title":"Suivi et orientation des femmes enceintes en fonction des situations \u00e0 risque identifi\u00e9es. Recommandations HAS","year":"2016"},{"key":"10.1016\/j.tracli.2026.08.003_bib1005","unstructured":"Arr\u00eat\u00e9 du 15\u00a0mai 2018\u00a0fixant les conditions de r\u00e9alisation des examens de biologie m\u00e9dicale d\u2019immuno-h\u00e9matologie \u00e9rythrocytaire. Journal Officiel 0116; 2018."},{"key":"10.1016\/j.tracli.2026.08.003_bib1010","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/tme.12299","article-title":"Guideline for blood grouping and red cell antibody testing in pregnancy","volume":"26","author":"White","year":"2016","journal-title":"Transfus Med"},{"key":"10.1016\/j.tracli.2026.08.003_bib1015","first-page":"S24","article-title":"Allo-immunisation foeto-maternelle \u00e9rythrocytaire (\u00e9tat des lieux sur la mani\u00e8re dont est r\u00e9alis\u00e9 le suivi IH des grossesses en France)","volume":"26","author":"Toly-Ndour","year":"2019","journal-title":"Transfus Clin Biol"},{"key":"10.1016\/j.tracli.2026.08.003_bib1020","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1016\/j.tracli.2021.08.103","article-title":"Groupe de travail AIFME (allo-immunisation foeto-maternelle anti-\u00e9rythrocytaire)\u202f: r\u00e9sultats de l\u2019enqu\u00eate sur les cas de mauvaises prises en charge foetale ou n\u00e9onatale li\u00e9s \u00e0 un d\u00e9faut de suivi immuno-h\u00e9matologique de la grossesse","volume":"28","author":"Toly-Ndour","year":"2021","journal-title":"Transfus Clin Biol"},{"key":"10.1016\/j.tracli.2026.08.003_bib1025","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1111\/1471-0528.13816","article-title":"Third trimester screening for alloimmunisation in Rhc-negative pregnant women: evaluation of the Dutch national screening programme","volume":"123","author":"Slootweg","year":"2016","journal-title":"BJOG Int J Obstet Gynaecol"},{"key":"10.1016\/j.tracli.2026.08.003_bib1030","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1472-6963-5-25","article-title":"Systems for grading the quality of evidence and the strength of recommendations II: pilot study of a new system","volume":"5","author":"Atkins","year":"2005","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.tracli.2026.08.003_bib1035","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.tracli.2026.08.003_bib1040","series-title":"Pr\u00e9vention de l\u2019allo-immunisation Rh\u00e9sus D chez les patientes de groupe Rh\u00e9sus D n\u00e9gatif. Recommandations pour la Pratique Clinique","year":"2017"},{"key":"10.1016\/j.tracli.2026.08.003_bib1045","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/ajo.12750","article-title":"The incidence and outcome of clinically significant antibodies detected in Rhesus-D positive pregnant women of the Northern Territory","volume":"58","author":"Andersson","year":"2018","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"10.1016\/j.tracli.2026.08.003_bib1050","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1111\/j.1537-2995.2007.01625.x","article-title":"Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands","volume":"48","author":"Koelewijn","year":"2008","journal-title":"Transfusion (Paris)"},{"key":"10.1016\/j.tracli.2026.08.003_bib1055","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/EDE.0000000000000805","article-title":"Evaluation of a decision tree for efficient antenatal red blood cell antibody screening","volume":"29","author":"Le Ray","year":"2018","journal-title":"Epidemiology"},{"key":"10.1016\/j.tracli.2026.08.003_bib1060","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1111\/j.1537-2995.2010.03006.x","article-title":"Severe hemolytic disease of fetus and newborn caused by red blood cell antibodies undetected at first-trimester screening (CME)","volume":"51","author":"Dajak","year":"2011","journal-title":"Transfusion (Paris)"},{"key":"10.1016\/j.tracli.2026.08.003_bib1065","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1093\/ije\/dyu079","article-title":"Associations of Rhesus and non-Rhesus maternal red blood cell alloimmunization with stillbirth and preterm birth","volume":"43","author":"Fan","year":"2014","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.tracli.2026.08.003_bib1070","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.tracli.2011.01.005","article-title":"[Management of feto-maternal red cell allo-immunizations]","volume":"18","author":"Bricca","year":"2011","journal-title":"Transfus Clin Biol"},{"key":"10.1016\/j.tracli.2026.08.003_bib1075","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/uog.7696","article-title":"Early intrauterine transfusion in severe red blood cell alloimmunization","volume":"36","author":"Yinon","year":"2010","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.tracli.2026.08.003_bib1080","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1111\/j.1537-2995.2009.02233.x","article-title":"Red blood cell antibodies in pregnancy and their clinical consequences: synergistic effects of multiple specificities","volume":"49","author":"Nordvall","year":"2009","journal-title":"Transfusion (Paris)"},{"key":"10.1016\/j.tracli.2026.08.003_bib1085","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/tme.12430","article-title":"A descriptive single-centre experience of the management and outcome of maternal alloantibodies in pregnancy","volume":"27","author":"Chatziantoniou","year":"2017","journal-title":"Transfus Med"},{"key":"10.1016\/j.tracli.2026.08.003_bib1090","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/pd.5355","article-title":"The near disappearance of fetal hydrops in relation to current state-of-the-art management of red cell alloimmunization","volume":"38","author":"Zwiers","year":"2018","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.tracli.2026.08.003_bib1095","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1365-3148.1995.tb00228.x","article-title":"Red cell antibodies in pregnancy: there is no \u201ccritical titre\u201d","volume":"5","author":"van Dijk","year":"1995","journal-title":"Transfus Med"},{"key":"10.1016\/j.tracli.2026.08.003_bib1100","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1080\/00016340802268880","article-title":"Alloimmunization in pregnancy during the years 1992\u20132005 in the central west region of Sweden","volume":"87","author":"Gottvall","year":"2008","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.tracli.2026.08.003_bib1105","doi-asserted-by":"crossref","first-page":"687","DOI":"10.3109\/00016349509021175","article-title":"The prevalence of red cell antibodies in pregnancy correlated to the outcome of the newborn: a 12 year study in central Sweden","volume":"74","author":"Filbey","year":"1995","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.tracli.2026.08.003_bib1110","doi-asserted-by":"crossref","first-page":"300","DOI":"10.3109\/00016349409015767","article-title":"Evaluation of standard parameters to predict exchange transfusions in the erythroblastotic newborn","volume":"73","author":"Gottvall","year":"1994","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.tracli.2026.08.003_bib1115","first-page":"246","article-title":"A case for comprehensive antenatal screening for blood group antibodies","volume":"49","author":"Anwar","year":"1999","journal-title":"J Pak Med Assoc"},{"key":"10.1016\/j.tracli.2026.08.003_bib1120","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s12288-015-0593-3","article-title":"Prevalence, specificity and titration of red cell alloantibodies in multiparous antenatal females at a tertiary care centre from North India","volume":"32","author":"Sidhu","year":"2016","journal-title":"Indian J Hematol Blood Transfus"},{"key":"10.1016\/j.tracli.2026.08.003_bib1125","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.transci.2013.04.021","article-title":"The risk assessment study for hemolytic disease of the fetus and newborn in a University Hospital in Turkey","volume":"48","author":"Altuntas","year":"2013","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.tracli.2026.08.003_bib1130","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1111\/trf.14453","article-title":"Successful management of severe red blood cell alloimmunization in pregnancy with a combination of therapeutic plasma exchange, intravenous immune globulin, and intrauterine transfusion","volume":"58","author":"Nwogu","year":"2018","journal-title":"Transfusion (Paris)"},{"key":"10.1016\/j.tracli.2026.08.003_bib1135","first-page":"518","article-title":"Survey on the prevention and incidence of haemolytic disease of the newborn in Italy","volume":"11","author":"Bennardello","year":"2013","journal-title":"Blood Transfus Trasfus Sangue"},{"key":"10.1016\/j.tracli.2026.08.003_bib1140","doi-asserted-by":"crossref","first-page":"434","DOI":"10.3109\/00016349309021130","article-title":"Evaluation of a new Swedish protocol for alloimmunization screening during pregnancy","volume":"72","author":"Gottvall","year":"1993","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.tracli.2026.08.003_bib1145","doi-asserted-by":"crossref","first-page":"127","DOI":"10.21307\/immunohematology-2019-134","article-title":"Prevalence of clinically significant red blood cell alloantibodies in pregnant women at a large tertiary-care facility","volume":"29","author":"Smith","year":"2013","journal-title":"Immunohematology"},{"key":"10.1016\/j.tracli.2026.08.003_bib1150","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1111\/trf.14944","article-title":"Severe hemolytic disease of the fetus and newborn due to allo-anti-D in a patient with a partial DEL phenotype arising from the variant allele described as RHD*148+1T (RHD*01EL.31)","volume":"58","author":"Turley","year":"2018","journal-title":"Transfusion (Paris)"},{"key":"10.1016\/j.tracli.2026.08.003_bib1155","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1111\/trf.14542","article-title":"Maternal red blood cell alloimmunization requiring intrauterine transfusion: a comparative study on management and outcome depending on the type of antibody","volume":"58","author":"Phung","year":"2018","journal-title":"Transfusion (Paris)"},{"key":"10.1016\/j.tracli.2026.08.003_bib1160","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1093\/labmed\/lmx061","article-title":"A case of a newborn with blocked RhD antigen and HDFN","volume":"48","author":"Wang","year":"2017","journal-title":"Lab Med"},{"key":"10.1016\/j.tracli.2026.08.003_bib1165","doi-asserted-by":"crossref","first-page":"e202","DOI":"10.1515\/cclm-2016-0545","article-title":"Usefulness of maternal red cell antibodies to predict hemolytic disease of the fetus and newborn and significant neonatal hyperbilirubinemia: a retrospective study","volume":"55","author":"Peeters","year":"2017","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.tracli.2026.08.003_bib1170","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/trf.14406","article-title":"Clinical input of anti-D quantitation by continuous-flow analysis on autoanalyzer in the management of high-titer anti-D maternal alloimmunization","volume":"58","author":"Toly-Ndour","year":"2018","journal-title":"Transfusion (Paris)"},{"key":"10.1016\/j.tracli.2026.08.003_bib1175","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1111\/j.1537-2995.2011.03538.x","article-title":"Anti-D in pregnant women with the RHD(IVS3+1G>A)-associated DEL phenotype","volume":"52","author":"Gardener","year":"2012","journal-title":"Transfusion (Paris)"},{"key":"10.1016\/j.tracli.2026.08.003_bib1180","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1111\/trf.14156","article-title":"Anti-D in a mother, hemizygous for the variant RHD*DNB gene, associated with hemolytic disease of the fetus and newborn","volume":"57","author":"Quantock","year":"2017","journal-title":"Transfusion (Paris)"},{"key":"10.1016\/j.tracli.2026.08.003_bib1185","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1111\/j.1471-0528.2009.02244.x","article-title":"Risk factors for RhD immunisation despite antenatal and postnatal anti-D prophylaxis","volume":"116","author":"Koelewijn","year":"2009","journal-title":"BJOG Int J Obstet Gynaecol"},{"key":"10.1016\/j.tracli.2026.08.003_bib1190","doi-asserted-by":"crossref","first-page":"68.e1","DOI":"10.1016\/j.ajog.2015.01.049","article-title":"Hemolytic disease of the fetus and newborn due to multiple maternal antibodies","volume":"213","author":"Markham","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.tracli.2026.08.003_bib1195","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3889\/oamjms.2015.058","article-title":"Correlation between the amount of anti-D antibodies and IgG subclasses with severity of haemolytic disease of foetus and newborn","volume":"3","author":"Velkova","year":"2015","journal-title":"Open Access Maced J Med Sci"},{"key":"10.1016\/j.tracli.2026.08.003_bib1200","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/tme.12176","article-title":"DAR boosted anti-D HDFN in a Caucasian family","volume":"25","author":"Pass","year":"2015","journal-title":"Transfus Med"},{"key":"10.1016\/j.tracli.2026.08.003_bib1205","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1111\/trf.12633","article-title":"Therapeutic plasma exchange and intravenous immunoglobulin as primary therapy for D alloimmunization in pregnancy precludes the need for intrauterine transfusion","volume":"54","author":"Bellone","year":"2014","journal-title":"Transfusion (Paris)"},{"key":"10.1016\/j.tracli.2026.08.003_bib1210","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1111\/aogs.12193","article-title":"Consequences of being Rhesus D immunized during pregnancy and how to optimize new prevention strategies","volume":"92","author":"Tiblad","year":"2013","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.tracli.2026.08.003_bib1215","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1111\/j.1537-2995.2012.03937.x","article-title":"Postnatal outcome in neonates with severe Rhesus c compared to rhesus D hemolytic disease","volume":"53","author":"Rath","year":"2013","journal-title":"Transfusion (Paris)"},{"key":"10.1016\/j.tracli.2026.08.003_bib1220","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.transci.2006.07.002","article-title":"A case of severe Rh (D) alloimmunization treated by intensive plasma exchange and high-dose intravenous immunoglobulin","volume":"35","author":"Palfi","year":"2006","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.tracli.2026.08.003_bib1225","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1159\/000086819","article-title":"Diagnosis and management of Rh alloimmunization","volume":"20","author":"Matijevic","year":"2005","journal-title":"Fetal Diagn Ther"},{"key":"10.1016\/j.tracli.2026.08.003_bib1230","first-page":"1143","article-title":"Fatal hydrops fetalis caused by anti-D in a mother with partial D","volume":"102","author":"Cannon","year":"2003","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.tracli.2026.08.003_bib1235","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1159\/000073145","article-title":"Intravenous fetal exchange transfusion before 22 weeks of gestation in early and severe red-cell fetomaternal alloimmunization","volume":"18","author":"Poissonnier","year":"2003","journal-title":"Fetal Diagn Ther"},{"key":"10.1016\/j.tracli.2026.08.003_bib1240","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1046\/j.1365-3148.2003.00458.x","article-title":"Haemolytic disease of the newborn due to maternal irregular antibodies in the Chinese population in Taiwan","volume":"13","author":"Wu","year":"2003","journal-title":"Transfus Med"},{"key":"10.1016\/j.tracli.2026.08.003_bib1245","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1067\/mob.2001.115999","article-title":"Management of isoimmunization in the presence of multiple maternal antibodies","volume":"185","author":"Spong","year":"2001","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.tracli.2026.08.003_bib1250","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1046\/j.1537-2995.1999.39111235.x","article-title":"Immunoglobulin administration to fetuses with anemia due to alloimmunization to D","volume":"39","author":"Ulm","year":"1999","journal-title":"Transfusion (Paris)"},{"key":"10.1016\/j.tracli.2026.08.003_bib1255","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1046\/j.1537-2995.1999.39299154731.x","article-title":"Male fetuses are particularly affected by maternal alloimmunization to D antigen","volume":"39","author":"Ulm","year":"1999","journal-title":"Transfusion (Paris)"},{"key":"10.1016\/j.tracli.2026.08.003_bib1260","doi-asserted-by":"crossref","first-page":"F62","DOI":"10.1136\/fn.78.1.F62","article-title":"Consequences for fetus and neonate of maternal red cell allo-immunisation","volume":"78","author":"Howard","year":"1998","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"10.1016\/j.tracli.2026.08.003_bib1265","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ejogrb.2013.09.002","article-title":"Relationship between maternal antibody type and antenatal course following intrauterine transfusion for red cell alloimmunisation","volume":"171","author":"Walsh","year":"2013","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.tracli.2026.08.003_bib1270","first-page":"55","article-title":"Severe anti-D haemolytic disease of fetal and newborn in rhesus D negative primigravida","volume":"41","author":"Hassan","year":"2019","journal-title":"Malays J Pathol"},{"key":"10.1016\/j.tracli.2026.08.003_bib1275","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/jca.21372","article-title":"Successful treatment of severe rhesus D-incompatible pregnancy with repeated double-filtration plasmapheresis","volume":"30","author":"Kamei","year":"2015","journal-title":"J Clin Apheresis"},{"key":"10.1016\/j.tracli.2026.08.003_bib1280","first-page":"565","article-title":"Severe hemolytic disease of the premature newborn due to RH1 incompatibility: a case report","volume":"89","author":"Uwingabiye","year":"2016","journal-title":"Clujul Med"},{"key":"10.1016\/j.tracli.2026.08.003_bib1285","doi-asserted-by":"crossref","first-page":"150","DOI":"10.4103\/0973-6247.162710","article-title":"Alloimmunization due to red cell antibodies in Rhesus positive Omani Pregnant Women: Maternal and Perinatal outcome","volume":"9","author":"Al-Dughaishi","year":"2015","journal-title":"Asian J Transfus Sci"},{"key":"10.1016\/j.tracli.2026.08.003_bib1290","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ejogrb.2007.03.003","article-title":"Current clinical management of anti-Kell alloimmunization in pregnancy","volume":"136","author":"Santiago","year":"2008","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.tracli.2026.08.003_bib1295","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1471-0528.2000.tb13266.x","article-title":"The outcome of pregnancy in Kell alloimmunisation","volume":"107","author":"Grant","year":"2000","journal-title":"BJOG Int J Obstet Gynaecol"},{"key":"10.1016\/j.tracli.2026.08.003_bib1300","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0368-2315(04)96605-7","article-title":"[Kell alloimmunization in pregnancy]","volume":"33","author":"Gariod","year":"2004","journal-title":"J Gynecol Obstet Biol Reprod (Paris)"},{"key":"10.1016\/j.tracli.2026.08.003_bib1305","first-page":"667","article-title":"Management of pregnancies complicated by anti-Kell isoimmunization","volume":"93","author":"McKenna","year":"1999","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.tracli.2026.08.003_bib1310","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1046\/j.1537-2995.2000.40101239.x","article-title":"Quantitative determination of anti-K (KEL1) IgG and IgG subclasses in the serum of severely alloimmunized pregnant women by ELISA","volume":"40","author":"Ahaded","year":"2000","journal-title":"Transfusion (Paris)"},{"key":"10.1016\/j.tracli.2026.08.003_bib1315","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.transci.2018.01.005","article-title":"A case of severe foetal anaemia due to anti-Kell that could not be detected by the weekly assessment of middle cerebral artery peak systolic velocity","volume":"57","author":"Deleers","year":"2018","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.tracli.2026.08.003_bib1320","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1097\/01.AOG.0000260957.77090.4e","article-title":"Obstetric history and antibody titer in estimating severity of Kell alloimmunization in pregnancy","volume":"109","author":"van Wamelen","year":"2007","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.tracli.2026.08.003_bib1325","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1111\/j.1537-2995.2007.01626.x","article-title":"Implementation of routine screening for Kell antibodies: does it improve perinatal survival?","volume":"48","author":"Kamphuis","year":"2008","journal-title":"Transfusion (Paris)"},{"key":"10.1016\/j.tracli.2026.08.003_bib1330","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.1471-0528.1991.tb13362.x","article-title":"Anti-Kell in pregnancy","volume":"98","author":"Leggat","year":"1991","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.tracli.2026.08.003_bib1335","first-page":"239","article-title":"Maternal Kell blood group alloimmunization","volume":"79","author":"Bowman","year":"1992","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.tracli.2026.08.003_bib1340","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2013-202750","article-title":"Bilateral cystic encephalomalacia following multiple intrauterine transfusions for anti-Kell isoimmunisation","volume":"2015","author":"Elsayed","year":"2015","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.tracli.2026.08.003_bib1345","first-page":"89","article-title":"The clinical outcome of non-RhD antibody affected pregnancies in Northern Ireland","volume":"70","author":"Chandrasekar","year":"2001","journal-title":"Ulster Med J"},{"key":"10.1016\/j.tracli.2026.08.003_bib1350","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s12098-011-0485-y","article-title":"Hemolytic disease of the newborn- anti c antibody induced hemolysis","volume":"79","author":"Murki","year":"2012","journal-title":"Indian J Pediatr"},{"key":"10.1016\/j.tracli.2026.08.003_bib1355","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s12288-012-0159-6","article-title":"Hemolytic disease of the newborn due to anti-c isoimmunization: a case report","volume":"29","author":"Sheeladevi","year":"2013","journal-title":"Indian J Hematol Blood Transfus"},{"key":"10.1016\/j.tracli.2026.08.003_bib1360","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/trf.15631","article-title":"Diagnostic value of laboratory monitoring to predict severe hemolytic disease of the fetus and newborn in non-D and non-K-alloimmunized pregnancies","volume":"60","author":"Koelewijn","year":"2020","journal-title":"Transfusion (Paris)"},{"key":"10.1016\/j.tracli.2026.08.003_bib1365","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.26719\/2001.7.6.1065","article-title":"Haemolytic disease of the newborn caused by rhesus isoimmunization (anti-c)","volume":"7","author":"Felc","year":"2001","journal-title":"East Mediterr Health J"},{"key":"10.1016\/j.tracli.2026.08.003_bib1370","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1002\/(SICI)1097-0223(199906)19:6<533::AID-PD570>3.0.CO;2-5","article-title":"Haemolytic disease of the newborn caused by anti-c, anti-E and anti-Fya antibodies: report of five cases","volume":"19","author":"Babinszki","year":"1999","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.tracli.2026.08.003_bib1375","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/01.AOG.0000109206.22354.2C","article-title":"Management of pregnancies complicated by anti-c isoimmunization","volume":"103","author":"Hackney","year":"2004","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.tracli.2026.08.003_bib1380","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1080\/10245330701448438","article-title":"First report from India of haemolytic disease of newborn by anti-c and anti-E in Rh (D) positive mothers","volume":"12","author":"Thakral","year":"2007","journal-title":"Hematology"},{"key":"10.1016\/j.tracli.2026.08.003_bib1385","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1111\/ped.13372","article-title":"Hemolytic disease of the newborn due to anti-E and anti-c antibody following maternal transfusion","volume":"59","author":"Yoda","year":"2017","journal-title":"Pediatr Int"},{"key":"10.1016\/j.tracli.2026.08.003_bib1390","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.arcped.2010.11.005","article-title":"[Fetomaternal anti-RH3, -4 (anti-E and anti-c) rhesus isoimmunization: a case report]","volume":"18","author":"Farnault","year":"2011","journal-title":"Arch Pediatr Organe"},{"key":"10.1016\/j.tracli.2026.08.003_bib1395","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/1752-1947-4-57","article-title":"Severe hydrops in the infant of a Rhesus D-positive mother due to anti-c antibodies diagnosed antenatally: a case report","volume":"4","author":"Singla","year":"2010","journal-title":"J Med Case Reports"},{"key":"10.1016\/j.tracli.2026.08.003_bib1400","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1365-3148.1995.tb00183.x","article-title":"Quantification of anti-c in haemolytic disease of the newborn","volume":"5","author":"Kozlowski","year":"1995","journal-title":"Transfus Med"},{"key":"10.1016\/j.tracli.2026.08.003_bib1405","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1111\/j.1471-0528.1986.tb07829.x","article-title":"The significance of anti-c alloimmunization in pregnancy","volume":"93","author":"Bowell","year":"1986","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.tracli.2026.08.003_bib1410","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/vox.13215","article-title":"Perinatal risk factors associated with severity of haemolytic disease of the foetus and newborn due to Rhc maternal-foetal incompatibility: a retrospective cohort study","volume":"117","author":"Franchinard","year":"2022","journal-title":"Vox Sang"},{"key":"10.1016\/j.tracli.2026.08.003_bib1415","first-page":"3736870","article-title":"Hydrops Fetalis and persistent pulmonary hypertension in a neonate with anti-E alloimmunization","volume":"2019","author":"Sharma","year":"2019","journal-title":"Case Rep Obstet Gynecol"},{"key":"10.1016\/j.tracli.2026.08.003_bib1420","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/01.AOG.0000149153.93417.66","article-title":"Management of pregnancies complicated by anti-E alloimmunization","volume":"105","author":"Joy","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.tracli.2026.08.003_bib1425","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1111\/j.1471-0528.2000.tb11662.x","article-title":"Anti-E in pregnancy","volume":"107","author":"Moran","year":"2000","journal-title":"BJOG Int J Obstet Gynaecol"},{"key":"10.1016\/j.tracli.2026.08.003_bib1430","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1046\/j.1341-8076.2003.00067.x","article-title":"Anti-E alloimmunization in pregnancy: management dilemmas","volume":"29","author":"To","year":"2003","journal-title":"J Obstet Gynaecol Res"},{"key":"10.1016\/j.tracli.2026.08.003_bib1435","doi-asserted-by":"crossref","first-page":"E126","DOI":"10.1111\/j.1440-1754.2010.01874.x","article-title":"Refractory cholestasis presenting as cholangiolitis in an Rh (E)-incompatible neonate","volume":"48","author":"Taba","year":"2012","journal-title":"J Paediatr Child Health"},{"key":"10.1016\/j.tracli.2026.08.003_bib1440","doi-asserted-by":"crossref","first-page":"84","DOI":"10.4103\/0973-6247.106750","article-title":"Hemolytic disease of the fetus and newborn caused by anti-E","volume":"7","author":"Usman","year":"2013","journal-title":"Asian J Transfus Sci"},{"key":"10.1016\/j.tracli.2026.08.003_bib1445","doi-asserted-by":"crossref","first-page":"471623","DOI":"10.1155\/2009\/471623","article-title":"Anti-e alloimmunization: a rare cause of severe fetal hemolytic disease resulting in pregnancy loss","volume":"2009","author":"Chao","year":"2009","journal-title":"Case Rep Med"},{"key":"10.1016\/j.tracli.2026.08.003_bib1450","doi-asserted-by":"crossref","first-page":"e229816","DOI":"10.1136\/bcr-2019-229816","article-title":"Haemolytic disease of the fetus and newborn diagnosed after delivery of a baby to a mother with low anti-E antibody titres","volume":"12","author":"Lee","year":"2019","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.tracli.2026.08.003_bib1455","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.3109\/14767050903544751","article-title":"Intravenous Immunoglobulin therapy for anti-E hemolytic disease in the newborn","volume":"23","author":"Onesimo","year":"2010","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.tracli.2026.08.003_bib1460","doi-asserted-by":"crossref","first-page":"58","DOI":"10.21307\/immunohematology-2019-174","article-title":"Possible suppression of fetal erythropoiesis by the Kell blood group antibody anti-Kp(a)","volume":"27","author":"Tuson","year":"2011","journal-title":"Immunohematology"},{"key":"10.1016\/j.tracli.2026.08.003_bib1465","doi-asserted-by":"crossref","first-page":"61","DOI":"10.21307\/immunohematology-2019-706","article-title":"A case of hemolytic disease of the newborn due to anti-Kpa","volume":"13","author":"Costamagna","year":"1997","journal-title":"Immunohematology"},{"key":"10.1016\/j.tracli.2026.08.003_bib1470","first-page":"140","article-title":"Severe hemolytic disease of the newborn due to anti-Js(b)","volume":"69","author":"Gordon","year":"1995","journal-title":"Vox Sang"},{"key":"10.1016\/j.tracli.2026.08.003_bib1475","first-page":"1145","article-title":"Is a third-trimester antibody screen in Rh+ women necessary?","volume":"5","author":"Rothenberg","year":"1999","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.tracli.2026.08.003_bib1480","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1080\/14767050601123317","article-title":"Should we continue screening rhesus D positive women for the development of atypical antibodies in late pregnancy?","volume":"20","author":"Adeniji","year":"2007","journal-title":"J Matern-Fetal Neonatal Med"},{"key":"10.1016\/j.tracli.2026.08.003_bib1485","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1111\/j.1537-2995.2007.01408.x","article-title":"Management of pregnancies complicated by anti-Fy(a) alloimmunization","volume":"47","author":"Hughes","year":"2007","journal-title":"Transfusion (Paris)"},{"key":"10.1016\/j.tracli.2026.08.003_bib1490","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1046\/j.1365-3148.1997.d01-38.x","article-title":"Haemolytic disease of the fetus and newborn due to anti-Fy(a) and the potential clinical value of Duffy genotyping in pregnancies at risk","volume":"7","author":"Goodrick","year":"1997","journal-title":"Transfus Med"},{"key":"10.1016\/j.tracli.2026.08.003_bib1495","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.transci.2010.05.007","article-title":"Hemolytic disease of newborn due to anti-Jk b in a woman with high risk pregnancy","volume":"43","author":"Thakral","year":"2010","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.tracli.2026.08.003_bib1500","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s12288-016-0688-5","article-title":"Clinical significance of rare maternal anti-Jka antibody","volume":"32","author":"Mittal","year":"2016","journal-title":"Indian J Hematol Blood Transfus"},{"key":"10.1016\/j.tracli.2026.08.003_bib1505","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/j.1537-2995.2007.01609.x","article-title":"Severe hemolytic disease of the fetus due to anti-Jkb","volume":"48","author":"Ferrando","year":"2008","journal-title":"Transfusion (Paris)"},{"key":"10.1016\/j.tracli.2026.08.003_bib1510","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/0002-9378(75)90467-6","article-title":"Hemolytic disease of the neonate secondary to anti-Fya","volume":"121","author":"Weinstein","year":"1975","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.tracli.2026.08.003_bib1515","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3346\/jkms.2006.21.1.151","article-title":"A fatal case of severe hemolytic disease of newborn associated with anti-Jk(b)","volume":"21","author":"Kim","year":"2006","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.tracli.2026.08.003_bib1520","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1097\/01.AOG.0000164060.89842.a9","article-title":"Severe hemolytic disease of the newborn due to anti-Cw","volume":"106","author":"Byers","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.tracli.2026.08.003_bib1525","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1055\/s-2006-934098","article-title":"Severe neonatal hemolysis due to a maternal antibody to the low-frequency Rh antigen C(w)","volume":"23","author":"May-Wewers","year":"2006","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.tracli.2026.08.003_bib1530","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/j.1651-2227.2005.tb01924.x","article-title":"Anti-C(w) alloimmunization presenting as hydrops fetalis","volume":"94","author":"Kollamparambil","year":"2005","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.tracli.2026.08.003_bib1535","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1046\/j.1537-2995.2000.40050571.x","article-title":"Severe HDN due to anti-Ce that required exchange transfusion","volume":"40","author":"Wagner","year":"2000","journal-title":"Transfusion (Paris)"},{"key":"10.1016\/j.tracli.2026.08.003_bib1540","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/trf.13367","article-title":"Severe case of fetal hemolytic disease caused by anti-C(w) requiring serial intrauterine transfusions complicated by pancytopenia and cholestasis","volume":"56","author":"Macher","year":"2016","journal-title":"Transfusion (Paris)"},{"key":"10.1016\/j.tracli.2026.08.003_bib1545","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1046\/j.1365-3148.2000.00268.x","article-title":"Haemolytic disease of the newborn due to anti-Ce","volume":"10","author":"Malde","year":"2000","journal-title":"Transfus Med"},{"key":"10.1016\/j.tracli.2026.08.003_bib1550","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1046\/j.1365-3148.2003.00412.x","article-title":"Anti-Ce complicating two consecutive pregnancies with increasing severity of haemolytic disease of the newborn","volume":"13","author":"Ranasinghe","year":"2003","journal-title":"Transfus Med"},{"key":"10.1016\/j.tracli.2026.08.003_bib1555","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1479-828X.1982.tb01433.x","article-title":"Haemolytic disease of the newborn associated with anti Cw","volume":"22","author":"Hughes","year":"1982","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"10.1016\/j.tracli.2026.08.003_bib1560","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1055\/s-2007-993872","article-title":"Use of a PCR-based assay for fetal Cw antigen genotyping in a patient with a history of moderately severe hemolytic disease of the newborn due to anti-Cw","volume":"16","author":"Reiner","year":"1999","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.tracli.2026.08.003_bib1565","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1365-2257.1988.tb00018.x","article-title":"The significance of anti-C sensitization in pregnancy","volume":"10","author":"Bowell","year":"1988","journal-title":"Clin Lab Haematol"},{"key":"10.1016\/j.tracli.2026.08.003_bib1570","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/S0002-9378(11)90614-0","article-title":"Severe anti-C hemolytic disease of the newborn","volume":"166","author":"Bowman","year":"1992","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.tracli.2026.08.003_bib1575","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s12288-016-0729-0","article-title":"What is it really? Anti-G or anti-D plus anti-C: clinical significance in antenatal mothers","volume":"33","author":"Das","year":"2017","journal-title":"Indian J Hematol Blood Transfus"},{"key":"10.1016\/j.tracli.2026.08.003_bib1580","first-page":"45","article-title":"Haemolytic disease of the newborn due to Rhesus anti-e antibody","volume":"41","author":"Chapman","year":"1981","journal-title":"Vox Sang"},{"key":"10.1016\/j.tracli.2026.08.003_bib1585","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/sj.jp.7211897","article-title":"Severe hemolytic disease of the newborn from anti-e","volume":"28","author":"McAdams","year":"2008","journal-title":"J Perinatol"},{"key":"10.1016\/j.tracli.2026.08.003_bib1590","doi-asserted-by":"crossref","first-page":"123","DOI":"10.21307\/immunohematology-2019-080","article-title":"Case report: Severe hemolytic disease of the fetus and newborn due to anti-C+G","volume":"31","author":"Jernman","year":"2015","journal-title":"Immunohematology"},{"key":"10.1016\/j.tracli.2026.08.003_bib1595","first-page":"108","article-title":"Haemolytic disease of the newborn due to anti-G","volume":"71","author":"Hadley","year":"1996","journal-title":"Vox Sang"},{"key":"10.1016\/j.tracli.2026.08.003_bib1600","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1093\/ajcp\/84.6.769","article-title":"Hemolytic disease of the newborn due to anti-C and anti-G masquerading as anti-D","volume":"84","author":"Yesus","year":"1985","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.tracli.2026.08.003_bib1605","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1097\/01.AOG.0000164061.08500.90","article-title":"Twin pregnancy complicated by severe hemolytic disease of the fetus and newborn due to anti-g and anti-C","volume":"106","author":"Trevett","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.tracli.2026.08.003_bib1610","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1111\/j.1537-2995.2007.01209.x","article-title":"Fetal hemolytic anemia and intrauterine death caused by anti-M immunization","volume":"47","author":"Wikman","year":"2007","journal-title":"Transfusion (Paris)"},{"key":"10.1016\/j.tracli.2026.08.003_bib1615","article-title":"Anti-M antibodies as a cause of intrauterine fetal death and neonatal hyperbilirubinaemia","volume":"2014","author":"Sharma","year":"2014","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.tracli.2026.08.003_bib1620","doi-asserted-by":"crossref","first-page":"3575","DOI":"10.1111\/trf.15578","article-title":"Cold reacting anti-M causing delayed hemolytic disease of the newborn","volume":"59","author":"Crispin","year":"2019","journal-title":"Transfusion (Paris)"},{"key":"10.1016\/j.tracli.2026.08.003_bib1625","doi-asserted-by":"crossref","first-page":"F467","DOI":"10.1136\/adc.2006.102954","article-title":"Neonatal pure red cell aplasia due to anti-M","volume":"91","author":"Hinchliffe","year":"2006","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"10.1016\/j.tracli.2026.08.003_bib1630","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tmrv.2013.10.002","article-title":"Hemolytic disease of the fetus and newborn with late-onset anemia due to anti-M: a case report and review of the Japanese literature","volume":"28","author":"Yasuda","year":"2014","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.tracli.2026.08.003_bib1635","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/trf.15054","article-title":"Hemolytic disease of the fetus and newborn due to alloanti-M: three Chinese case reports and a review of the literature","volume":"59","author":"Li","year":"2019","journal-title":"Transfusion (Paris)"},{"key":"10.1016\/j.tracli.2026.08.003_bib1640","first-page":"91","article-title":"Hemolytic disease of the newborn due to anti S antibodies","volume":"92","author":"Parsh","year":"2000","journal-title":"J Natl Med Assoc"},{"key":"10.1016\/j.tracli.2026.08.003_bib1645","doi-asserted-by":"crossref","first-page":"128","DOI":"10.4103\/2249-4847.134719","article-title":"Severe hemolytic disease of fetus and newborn due to anti-s antibodies","volume":"3","author":"Reddy","year":"2014","journal-title":"J Clin Neonatol"},{"key":"10.1016\/j.tracli.2026.08.003_bib1650","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1365-2257.1990.tb01117.x","article-title":"The significance of anti-S sensitization in pregnancy","volume":"12","author":"Mayne","year":"1990","journal-title":"Clin Lab Haematol"},{"key":"10.1016\/j.tracli.2026.08.003_bib1655","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.0958-7578.2005.00566.x","article-title":"Use of red cells preserved in extended storage media for exchange transfusion in anti-k haemolytic disease of the newborn","volume":"15","author":"Win","year":"2005","journal-title":"Transfus Med"},{"key":"10.1016\/j.tracli.2026.08.003_bib1660","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1159\/000448381","article-title":"Clinical significance of an alloantibody against the Kell Blood Group Glycoprotein","volume":"44","author":"Mattaloni","year":"2017","journal-title":"Transfus Med Hemotherapy"},{"key":"10.1016\/j.tracli.2026.08.003_bib1665","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/trf.12331","article-title":"Successful management of severe hemolytic disease of the fetus due to anti-Jsb using intrauterine transfusions with serial maternal blood donations: a case report and a review of the literature","volume":"54","author":"Al Riyami","year":"2014","journal-title":"Transfusion (Paris)"},{"key":"10.1016\/j.tracli.2026.08.003_bib1670","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1111\/j.1537-2995.2005.00604.x","article-title":"Serial blood donations for intrauterine transfusions of severe hemolytic disease of the newborn with the use of recombinant erythropoietin in a pregnant woman alloimmunized with anti-Ku","volume":"45","author":"Lydaki","year":"2005","journal-title":"Transfusion (Paris)"},{"key":"10.1016\/j.tracli.2026.08.003_bib1675","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1046\/j.1537-2995.1978.18478251242.x","article-title":"Severe hemolytic disease of the newborn associated with anti-JSb","volume":"18","author":"Lowe","year":"1978","journal-title":"Transfusion (Paris)"},{"key":"10.1016\/j.tracli.2026.08.003_bib1680","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.transci.2006.09.004","article-title":"Anti-KEL7 (anti-Js(b)) alloimmunization diagnostic supported by molecular KEL*6,7 typing in a pregnant woman with previous intrauterine deaths","volume":"35","author":"Botur\u00e3o-Neto","year":"2006","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.tracli.2026.08.003_bib1685","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1046\/j.1423-0410.2001.00092.x","article-title":"Severe haemolytic disease of the newborn due to anti-Js(b)","volume":"81","author":"Stanworth","year":"2001","journal-title":"Vox Sang"},{"key":"10.1016\/j.tracli.2026.08.003_bib1690","first-page":"779","article-title":"[The Ko phenotype and fetal-maternal allo-immunization]","volume":"50","author":"Fourmaintraux","year":"1993","journal-title":"Arch Fr Pediatr"},{"key":"10.1016\/j.tracli.2026.08.003_bib1695","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/0002-9378(84)90469-1","article-title":"Severe erythroblastosis fetalis secondary to anti-Kpb sensitization","volume":"150","author":"Dacus","year":"1984","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.tracli.2026.08.003_bib1700","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1080\/08880010601001453","article-title":"Use of recombinant erythropoietin for the management of severe hemolytic disease of the newborn of a K0 phenotype mother","volume":"24","author":"Manoura","year":"2007","journal-title":"Pediatr Hematol Oncol"},{"key":"10.1016\/j.tracli.2026.08.003_bib1705","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1046\/j.1537-2995.1980.20681057162.x","article-title":"A second case of hemolytic disease of the newborn due to anti-Jsa","volume":"20","author":"Levene","year":"1980","journal-title":"Transfusion (Paris)"},{"key":"10.1016\/j.tracli.2026.08.003_bib1710","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/trf.13852","article-title":"Fatal hemolytic disease of the newborn caused by an antibody to KEAL, a new low-prevalence Kell blood group antigen","volume":"57","author":"Scharberg","year":"2017","journal-title":"Transfusion (Paris)"},{"key":"10.1016\/j.tracli.2026.08.003_bib1715","first-page":"187","article-title":"Erythroblastosis fetalis produced by anti-k","volume":"56","author":"Bowman","year":"1989","journal-title":"Vox Sang"},{"key":"10.1016\/j.tracli.2026.08.003_bib1720","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.tracli.2021.04.007","article-title":"Maternal red blood cell alloimmunisation Working Party, literature review. RH blood group system: rare specificities","volume":"28","author":"Floch","year":"2021","journal-title":"Transfus Clin Biol J"},{"key":"10.1016\/j.tracli.2026.08.003_bib1725","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1159\/000467299","article-title":"Hemolytic disease of the newborn due to anti-N","volume":"31","author":"Telischi","year":"1976","journal-title":"Vox Sang"},{"key":"10.1016\/j.tracli.2026.08.003_bib1730","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1111\/trf.13806","article-title":"Autologous intrauterine transfusion in a case of anti-U","volume":"56","author":"Adam","year":"2016","journal-title":"Transfusion (Paris)"},{"key":"10.1016\/j.tracli.2026.08.003_bib1735","first-page":"221","article-title":"Anti-U alloimmunisation in a pregnant woman from Niger","volume":"10","author":"Ringressi","year":"2012","journal-title":"Blood Transfus Trasfus Sangue"},{"key":"10.1016\/j.tracli.2026.08.003_bib1740","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1590\/S0041-87812003000600006","article-title":"Hemolytic disease of the newborn due to anti-U","volume":"58","author":"Novaretti","year":"2003","journal-title":"Rev Hosp Clin"},{"key":"10.1016\/j.tracli.2026.08.003_bib1745","doi-asserted-by":"crossref","first-page":"51","DOI":"10.21307\/immunohematology-2019-124","article-title":"Hemolytic disease of the fetus and newborn owing to anti-U, successfully treated with repeated intrauterine transfusions","volume":"29","author":"Strindberg","year":"2013","journal-title":"Immunohematology"},{"key":"10.1016\/j.tracli.2026.08.003_bib1750","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1111\/j.1471-0528.1998.tb10013.x","article-title":"Anti-U and haemolytic disease of the fetus and newborn","volume":"105","author":"Smith","year":"1998","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.tracli.2026.08.003_bib1755","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/j.1600-0412.2010.01106.x","article-title":"Anti-U antibody in pregnancy: a rare antibody causing hemolytic disease","volume":"90","author":"Rana","year":"2011","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.tracli.2026.08.003_bib1760","doi-asserted-by":"crossref","first-page":"37","DOI":"10.21307\/immunohematology-2019-506","article-title":"Anti-Mta associated with three cases of hemolytic disease of the newborn","volume":"18","author":"Cheung","year":"2002","journal-title":"Immunohematology"},{"key":"10.1016\/j.tracli.2026.08.003_bib1765","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1111\/trf.15709","article-title":"Fetal inheritance of GP*Mur causing severe HDFN in an unrecognized case of maternal alloimmunization","volume":"60","author":"Mallari","year":"2020","journal-title":"Transfusion (Paris)"},{"key":"10.1016\/j.tracli.2026.08.003_bib1770","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1515\/JPM.2009.071","article-title":"Severe neonatal hyporegenerative anemia due to anti-Vw (anti-MNS9) alloantibody","volume":"37","author":"Waldvogel","year":"2009","journal-title":"J Perinat Med"},{"key":"10.1016\/j.tracli.2026.08.003_bib1775","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1046\/j.1537-2995.1996.361097017185.x","article-title":"Anti-Vw causing a case of clinically significant hemolytic disease of the newborn","volume":"36","author":"Gorlin","year":"1996","journal-title":"Transfusion (Paris)"},{"key":"10.1016\/j.tracli.2026.08.003_bib1780","first-page":"318","article-title":"Severe hemolytic disease of the newborn due to anti-Vw and detection of glycophorin A antigens on the Miltenberger I sialoglycoprotein by Western blotting","volume":"52","author":"Rearden","year":"1987","journal-title":"Vox Sang"},{"key":"10.1016\/j.tracli.2026.08.003_bib1785","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1046\/j.1537-2995.1982.22282177130.x","article-title":"A case of severe hemolytic disease of the newborn due to anti-Verweyst (Vw)","volume":"22","author":"Taylor","year":"1982","journal-title":"Transfusion (Paris)"},{"key":"10.1016\/j.tracli.2026.08.003_bib1790","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.3109\/14767050903366085","article-title":"Severe hemolytic disease of the fetus and the newborn associated with anti-Vw (Vw)","volume":"23","author":"Moncharmont","year":"2010","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.tracli.2026.08.003_bib1795","doi-asserted-by":"crossref","first-page":"151","DOI":"10.21307\/immunohematology-2019-021","article-title":"Anti-Vel alloimmunization and severe hemolytic disease of the fetus and newborn","volume":"33","author":"Moise","year":"2017","journal-title":"Immunohematology"},{"key":"10.1016\/j.tracli.2026.08.003_bib1800","first-page":"899","article-title":"[Severe form of neonatal hemolytic disease by anti-Vel allo-immunization]","volume":"49","author":"Le Masne","year":"1992","journal-title":"Arch Fr Pediatr"},{"key":"10.1016\/j.tracli.2026.08.003_bib1805","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1111\/trf.12473","article-title":"Hemolytic disease of the fetus and newborn caused by anti-Lan","volume":"54","author":"Brooks","year":"2014","journal-title":"Transfusion (Paris)"},{"key":"10.1016\/j.tracli.2026.08.003_bib1810","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1111\/j.1537-2995.2008.01787.x","article-title":"Fatal hemolytic disease of the fetus and newborn associated with anti-Jr","volume":"48","author":"Peyrard","year":"2008","journal-title":"Transfusion (Paris)"},{"key":"10.1016\/j.tracli.2026.08.003_bib1815","doi-asserted-by":"crossref","first-page":"102605","DOI":"10.1016\/j.transci.2019.06.029","article-title":"Fatal hemolytic disease of the fetus and newborn caused by anti-Jra antibody: a case report and literature review","volume":"59","author":"Kim","year":"2020","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.tracli.2026.08.003_bib1820","first-page":"347","article-title":"A case of severe haemolytic disease of the newborn due to anti-Di(a) antibody","volume":"10","author":"Ting","year":"2004","journal-title":"Hong Kong Med J"},{"key":"10.1016\/j.tracli.2026.08.003_bib1825","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1891\/0730-0832.31.2.69","article-title":"Hemolytic disease of the newborn caused by anti-Wright (anti-Wra): case report and review of literature","volume":"31","author":"Squires","year":"2012","journal-title":"Neonatal Netw"},{"key":"10.1016\/j.tracli.2026.08.003_bib1830","first-page":"80","article-title":"Severe hemolytic disease of the newborn due to anti-Di b treated with phototherapy and intravenous immunoglobulin","volume":"38","author":"Oh","year":"2008","journal-title":"Ann Clin Lab Sci"},{"key":"10.1016\/j.tracli.2026.08.003_bib1835","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1365-3148.2007.00799.x","article-title":"Anti-Co(a) implicated in severe haemolytic disease of the foetus and newborn","volume":"18","author":"Michalewska","year":"2008","journal-title":"Transfus Med"},{"key":"10.1016\/j.tracli.2026.08.003_bib1840","series-title":"Dictionnaire des antig\u00e8nes \u00e9rythrocytaires immunogenes","author":"Bizot","year":"1990"},{"key":"10.1016\/j.tracli.2026.08.003_bib1845","series-title":"Human blood groups.","author":"Daniels","year":"2013"},{"key":"10.1016\/j.tracli.2026.08.003_bib1850","series-title":"Les groupes sanguins \u00e9rythrocytaires","author":"Chiarioni","year":"2024"},{"key":"10.1016\/j.tracli.2026.08.003_bib1855","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/vox.13042","article-title":"Clinical consequences of the extremely rare anti-PP1Pk isoantibodies in pregnancy: a case series and review of the literature","volume":"116","author":"Di Ciaccio","year":"2021","journal-title":"Vox Sang"},{"key":"10.1016\/j.tracli.2026.08.003_bib1860","doi-asserted-by":"crossref","first-page":"54","DOI":"10.14740\/jmc4047","article-title":"Severe hemolytic disease of the newborn due to anti-Dia","volume":"14","author":"Blackall","year":"2023","journal-title":"J Med Cases"},{"key":"10.1016\/j.tracli.2026.08.003_bib1865","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/j.1537-2995.2006.00743.x","article-title":"Hemolytic disease of the newborn due to anti-Di: a case study and review of the literature","volume":"46","author":"Mochizuki","year":"2006","journal-title":"Transfusion (Paris)"},{"key":"10.1016\/j.tracli.2026.08.003_bib1870","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1046\/j.1537-2995.1987.27387235637.x","article-title":"Studies on the blood of a Co (a-b-) proposita and her family","volume":"27","author":"Lacey","year":"1987","journal-title":"Transfusion (Paris)"},{"key":"10.1016\/j.tracli.2026.08.003_bib1875","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.0958-7578.2005.00562.x","article-title":"Late onset neonatal anaemia due to maternal anti-Ge: possible association with destruction of eythroid progenitors","volume":"15","author":"Arndt","year":"2005","journal-title":"Transfus Med"},{"key":"10.1016\/j.tracli.2026.08.003_bib1880","doi-asserted-by":"crossref","first-page":"e27014","DOI":"10.1002\/pbc.27014","article-title":"Molecular characterization and multidisciplinary management of Gerbich hemolytic disease of the newborn","volume":"65","author":"Levitt","year":"2018","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.tracli.2026.08.003_bib1885","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1111\/trf.12027","article-title":"Anti-Ge3 causes late-onset hemolytic disease of the newborn: the fourth case in three Hispanic families","volume":"53","author":"Pate","year":"2013","journal-title":"Transfusion (Paris)"},{"key":"10.1016\/j.tracli.2026.08.003_bib1890","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1537-2995.1973.tb05479.x","article-title":"Six additional examples of anti-Ata","volume":"13","author":"Gellerman","year":"1973","journal-title":"Transfusion (Paris)"},{"key":"10.1016\/j.tracli.2026.08.003_bib1895","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1046\/j.1537-2995.1999.39080834.x","article-title":"Severe delayed hemolytic transfusion reaction secondary to anti-At(a)","volume":"39","author":"Cash","year":"1999","journal-title":"Transfusion (Paris)"},{"key":"10.1016\/j.tracli.2026.08.003_bib1900","first-page":"16","article-title":"Quantification des anticorps anti-\u00e9rythrocytaires chez la femme enceinte","volume":"347","author":"Toly-Ndour","year":"2019","journal-title":"Rev Biol Med"},{"key":"10.1016\/j.tracli.2026.08.003_bib1905","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1423-0410.2008.01043.x","article-title":"Reducing the variation in performance of antibody titrations","volume":"95","author":"AuBuchon","year":"2008","journal-title":"Vox Sang"},{"key":"10.1016\/j.tracli.2026.08.003_bib1910","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/tme.12002","article-title":"Antenatal monitoring of anti-D and anti-c: could titre scores determined by column agglutination technology replace continuous flow analyser quantification?","volume":"23","author":"Bruce","year":"2013","journal-title":"Transfus Med"},{"key":"10.1016\/j.tracli.2026.08.003_bib1915","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/0002-9378(95)90034-9","article-title":"The predictive value of maternal serum testing for detection of fetal anemia in red blood cell alloimmunization","volume":"172","author":"Moise","year":"1995","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.tracli.2026.08.003_bib1920","doi-asserted-by":"crossref","first-page":"8","DOI":"10.21307\/immunohematology-2019-194","article-title":"Role for serial prenatal anti-Vel quantitative serologic monitoring with 2-ME serum treatment during pregnancy: case report","volume":"26","author":"Linz","year":"2010","journal-title":"Immunohematology"},{"key":"10.1016\/j.tracli.2026.08.003_bib1925","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/tme.12661","article-title":"Monitoring of prenatal patients using a combined antibody titre for Rh and non-Rh antibodies","volume":"30","author":"Farrell","year":"2020","journal-title":"Transfus Med"},{"key":"10.1016\/j.tracli.2026.08.003_bib1930","doi-asserted-by":"crossref","first-page":"62","DOI":"10.4103\/0973-6247.200770","article-title":"Anti-G with concomitant anti-C and anti-D: a case report in a pregnant woman","volume":"11","author":"Yousuf","year":"2017","journal-title":"Asian J Transfus Sci"},{"key":"10.1016\/j.tracli.2026.08.003_bib1935","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1046\/j.1537-2995.1997.37597293879.x","article-title":"Differentiation of anti-D, -C, and -G: clinical relevance in alloimmunized pregnancies","volume":"37","author":"Shirey","year":"1997","journal-title":"Transfusion (Paris)"},{"key":"10.1016\/j.tracli.2026.08.003_bib1940","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.tracli.2007.10.001","article-title":"[Microtitration of anti-RH1 antibodies: interest in the follow-up of pregnant women]","volume":"14","author":"Dupont","year":"2007","journal-title":"Transfus Clin Biol J"},{"key":"10.1016\/j.tracli.2026.08.003_bib1945","first-page":"11","article-title":"Diagnostic et suivi pr\u00e9natals des allo-immunisations \u00e9rythrocytaires","volume":"43","author":"Brossard","year":"2002","journal-title":"Feuill Biol"},{"key":"10.1016\/j.tracli.2026.08.003_bib1950","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0378-3782(87)90095-8","article-title":"The evaluation of maternal anti-D concentrations during pregnancy","volume":"15","author":"Filbey","year":"1987","journal-title":"Early Hum Dev"},{"key":"10.1016\/j.tracli.2026.08.003_bib1955","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/trf.17264","article-title":"Anti-RH1 alloimmunization: at what maternal antibody threshold is there a risk of severe fetal anemia?","volume":"63","author":"Ghesqui\u00e8re","year":"2023","journal-title":"Transfusion (Paris)"},{"key":"10.1016\/j.tracli.2026.08.003_bib1960","series-title":"Surveillance Immunoh\u00e9matologique de la femme enceinte allo-immunis\u00e9e","year":"2025"},{"key":"10.1016\/j.tracli.2026.08.003_bib1965","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1136\/bmj.285.6338.327","article-title":"Maternal anti-D concentrations and outcome in rhesus haemolytic disease of the newborn","volume":"285","author":"Bowell","year":"1982","journal-title":"Br Med J"},{"key":"10.1016\/j.tracli.2026.08.003_bib1970","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1365-2141.1991.tb07981.x","article-title":"Correlation of serological, quantitative and cell-mediated functional assays of maternal alloantibodies with the severity of haemolytic disease of the newborn","volume":"77","author":"Hadley","year":"1991","journal-title":"Br J Haematol"},{"key":"10.1016\/j.tracli.2026.08.003_bib1975","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1046\/j.1423-0410.1997.73100546_71_4.x","article-title":"A retrospective study of red cell maternal antibodies by chemiluminescence","volume":"71","author":"Downing","year":"1996","journal-title":"Vox Sang"},{"key":"10.1016\/j.tracli.2026.08.003_bib1980","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1136\/bmj.304.6835.1155","article-title":"Maternal serum anti-D antibody concentration and assessment of rhesus isoimmunisation","volume":"304","author":"Nicolaides","year":"1992","journal-title":"BMJ"},{"key":"10.1016\/j.tracli.2026.08.003_bib1985","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.siny.2008.02.007","article-title":"Fetal anemia due to non-Rhesus-D red-cell alloimmunization","volume":"13","author":"Moise","year":"2008","journal-title":"Semin Fetal Neonatal Med"},{"key":"10.1016\/j.tracli.2026.08.003_bib1990","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1423-0410.2010.01322.x","article-title":"Monitoring and treatment of anti-D in pregnancy","volume":"99","author":"Bettelheim","year":"2010","journal-title":"Vox Sang"},{"key":"10.1016\/j.tracli.2026.08.003_bib1995","doi-asserted-by":"crossref","first-page":"150895","DOI":"10.1016\/j.tmrv.2025.150895","article-title":"The Utility of a critical antibody titer in anti-K alloimmunized pregnancies: a systematic review and meta-analysis of diagnostic test accuracy","volume":"39","author":"Jacobs","year":"2025","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.tracli.2026.08.003_bib2000","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/vox.12265","article-title":"Haemolytic disease of the fetus and newborn","volume":"109","author":"de Haas","year":"2015","journal-title":"Vox Sang"},{"key":"10.1016\/j.tracli.2026.08.003_bib2005","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1159\/000518782","article-title":"Laboratory monitoring of mother, fetus, and newborn in hemolytic disease of fetus and newborn","volume":"48","author":"Dziegiel","year":"2021","journal-title":"Transfus Med Hemotherapy"},{"key":"10.1016\/j.tracli.2026.08.003_bib2010","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.tmrv.2018.07.002","article-title":"Red blood cell alloimmunization in the pregnant patient","volume":"32","author":"Webb","year":"2018","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.tracli.2026.08.003_bib2015","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1046\/j.1537-2995.2001.41111445.x","article-title":"Practice guidelines for prenatal and perinatal immunohematology, revisited","volume":"41","author":"Judd","year":"2001","journal-title":"Transfusion (Paris)"},{"key":"10.1016\/j.tracli.2026.08.003_bib2020","first-page":"109","article-title":"Recommendations for the prevention and treatment of haemolytic disease of the foetus and newborn","volume":"13","author":"Bennardello","year":"2015","journal-title":"Blood Transfus"},{"key":"10.1016\/j.tracli.2026.08.003_bib2025","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/trf.70022","article-title":"D-Alloantibody Titration Assessment Study: In Search of a Common Antibody Titration Platform-A BEST Collaborative Study","volume":"66","author":"Aldarweesh","year":"2026","journal-title":"Transfusion (Paris)"},{"key":"10.1016\/j.tracli.2026.08.003_bib2030","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/vox.12716","article-title":"Anti-D quantification in relation to anti-D titre, middle cerebral artery Doppler measurement and clinical outcome in RhD-immunized pregnancies","volume":"113","author":"Wikman","year":"2018","journal-title":"Vox Sang"},{"key":"10.1016\/j.tracli.2026.08.003_bib2035","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1046\/j.1365-2257.2003.00540.x","article-title":"Comparison of conventional tube test with diamed gel microcolumn assay for anti-D titration","volume":"25","author":"Novaretti","year":"2003","journal-title":"Clin Lab Haematol"},{"key":"10.1016\/j.tracli.2026.08.003_bib2040","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1111\/j.1537-2995.2012.03793.x","article-title":"Comparison of a gel microcolumn assay with the conventional tube test for red blood cell alloantibody titration","volume":"53","author":"Finck","year":"2013","journal-title":"Transfusion (Paris)"},{"key":"10.1016\/j.tracli.2026.08.003_bib2045","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1002\/uog.13383","article-title":"Reassessing critical maternal antibody threshold in RhD alloimmunization: a 16-year retrospective cohort study","volume":"44","author":"Walsh","year":"2014","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.tracli.2026.08.003_bib2050","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S1473-0502(02)00068-X","article-title":"Prediction of fetal Rh D and Rh CcEe phenotype from maternal plasma with real-time polymerase chain reaction","volume":"27","author":"Legler","year":"2002","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.tracli.2026.08.003_bib2055","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1159\/000085085","article-title":"Non-invasive fetal RHD exon 7 and exon 10 genotyping using real-time PCR testing of fetal DNA in maternal plasma","volume":"20","author":"Hromadnikova","year":"2005","journal-title":"Fetal Diagn Ther"},{"key":"10.1016\/j.tracli.2026.08.003_bib2060","first-page":"101","article-title":"Noninvasive fetal blood group antigen genotyping","volume":"23","author":"Clausen","year":"2025","journal-title":"Blood Transfus Trasfus Sangue"},{"key":"10.1016\/j.tracli.2026.08.003_bib2065","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1111\/j.1537-2995.2007.01437.x","article-title":"Fetal genotyping for the K (Kell) and Rh C, c, and E blood groups on cell-free fetal DNA in maternal plasma","volume":"47","author":"Finning","year":"2007","journal-title":"Transfusion (Paris)"},{"key":"10.1016\/j.tracli.2026.08.003_bib2070","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1111\/j.1471-0528.2011.03028.x","article-title":"Noninvasive fetal blood group genotyping of rhesus D, c, E and of K in alloimmunised pregnant women: evaluation of a 7-year clinical experience","volume":"118","author":"Scheffer","year":"2011","journal-title":"BJOG Int J Obstet Gynaecol"},{"key":"10.1016\/j.tracli.2026.08.003_bib2075","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/pd.1977","article-title":"Preliminary results of fetal Rhc examination in plasma of pregnant women with anti-c","volume":"28","author":"Orzi\u0144ska","year":"2008","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.tracli.2026.08.003_bib2080","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1537-2995.2007.01533.x","article-title":"Routine fetal RHD genotyping with maternal plasma: a four-year experience in Belgium","volume":"48","author":"Minon","year":"2008","journal-title":"Transfusion (Paris)"},{"key":"10.1016\/j.tracli.2026.08.003_bib2085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tracli.2013.12.001","article-title":"[Non-invasive fetal RHD genotyping: validation of the method with 200 patients]","volume":"21","author":"Guinchard","year":"2014","journal-title":"Transfus Clin Biol J"},{"key":"10.1016\/j.tracli.2026.08.003_bib2090","first-page":"23","article-title":"Large-scale pre-diagnosis study of fetal RHD genotyping by PCR on plasma DNA from RhD-negative pregnant women","volume":"8","author":"Rouillac-Le Sciellour","year":"2004","journal-title":"Mol Diagn J Devoted Underst Hum Dis Clin Appl Mol Biol"},{"key":"10.1016\/j.tracli.2026.08.003_bib2095","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.tracli.2008.01.003","article-title":"Noninvasive fetal RHD genotyping from maternal plasma. Use of a new developed Free DNA Fetal Kit RhD","volume":"14","author":"Rouillac-Le Sciellour","year":"2007","journal-title":"Transfus Clin Biol J"},{"key":"10.1016\/j.tracli.2026.08.003_bib2100","first-page":"354","article-title":"Le g\u00e9notypage RHD foetal non invasif","author":"Delaby-Fekkar","year":"2020","journal-title":"Rev Biol Med"},{"key":"10.1016\/j.tracli.2026.08.003_bib2105","series-title":"D\u00e9termination pr\u00e9natale du g\u00e9notype RHD foetal \u00e0 partir du sang maternel. Rapport d\u2019\u00e9valuation technologique de la HAS","year":"2011"},{"key":"10.1016\/j.tracli.2026.08.003_bib2110","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.gyobfe.2007.11.017","article-title":"[Non invasive fetal RhD genotyping using maternal blood: time for use in all RhD negative pregnant women]","volume":"36","author":"Carbonne","year":"2008","journal-title":"Gynecol Obstet Fertil"},{"key":"10.1016\/j.tracli.2026.08.003_bib2115","article-title":"Diagnostic et suivi biologiques des allo-immunisations anti-\u00e9rythrocytaires chez la femme enceinte","author":"Huguet-Jacquot","year":"2015","journal-title":"Rev Francoph Lab"},{"key":"10.1016\/j.tracli.2026.08.003_bib2120","first-page":"1","article-title":"Allo-immunisation \u00e9rythrocytaire maternofoetale","volume":"49","author":"Maurice","year":"2026","journal-title":"EMC Obstet Gynecol"},{"key":"10.1016\/j.tracli.2026.08.003_bib2125","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1046\/j.1537-2995.2003.00313.x","article-title":"Testing for the D zygosity with three different methods revealed altered Rhesus boxes and a new weak D type","volume":"43","author":"Perco","year":"2003","journal-title":"Transfusion (Paris)"},{"key":"10.1016\/j.tracli.2026.08.003_bib2130","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1373\/clinchem.2016.268698","article-title":"Rapid RHD zygosity determination using digital PCR","volume":"63","author":"Sillence","year":"2017","journal-title":"Clin Chem"},{"key":"10.1016\/j.tracli.2026.08.003_bib2135","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1002\/pd.2652","article-title":"Molecular determination of RHD zygosity: predicting risk of hemolytic disease of the fetus and newborn related to anti-D","volume":"30","author":"Pirelli","year":"2010","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.tracli.2026.08.003_bib2140","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/j.1537-2995.2007.01175.x","article-title":"Quantitation of RHD by real-time polymerase chain reaction for determination of RHD zygosity and RHD mosaicism\/chimerism: an evaluation of four quantitative methods","volume":"47","author":"Krog","year":"2007","journal-title":"Transfusion (Paris)"},{"key":"10.1016\/j.tracli.2026.08.003_bib2145","series-title":"Sortie de maternit\u00e9 apr\u00e8s accouchement\u00a0: conditions et organisation du retour \u00e0 domicile des m\u00e8res et de leurs nouveau-n\u00e9s. Recommandations HAS","year":"2014"},{"key":"10.1016\/j.tracli.2026.08.003_bib2150","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.1542\/peds.109.4.e53","article-title":"An early (sixth-hour) serum bilirubin measurement is useful in predicting the development of significant hyperbilirubinemia and severe ABO hemolytic disease in a selective high-risk population of newborns with ABO incompatibility","volume":"109","author":"Sarici","year":"2002","journal-title":"Pediatrics"},{"key":"10.1016\/j.tracli.2026.08.003_bib2155","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1001\/archpediatrics.2010.242","article-title":"Hour-specific bilirubin nomogram in infants with ABO incompatibility and direct Coombs-positive results","volume":"164","author":"Schutzman","year":"2010","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.tracli.2026.08.003_bib2160","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.arcped.2016.11.011","article-title":"Ict\u00e8re \u00e0 bilirubine non conjug\u00e9e du nouveau-n\u00e9 de 35 semaines et plus\u202f: du d\u00e9pistage au suivi apr\u00e8s sortie de la maternit\u00e9","volume":"24","author":"Cortey","year":"2017","journal-title":"Arch Pediatr"},{"key":"10.1016\/j.tracli.2026.08.003_bib2165","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.jgyn.2010.02.006","article-title":"[What blood tests to predict severe hyperbilirubinemia in early maternity discharge?]","volume":"39","author":"Tatopoulos","year":"2010","journal-title":"J Gynecol Obstet Biol Reprod (Paris)"},{"key":"10.1016\/j.tracli.2026.08.003_bib2170","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.plabm.2015.10.001","article-title":"Comparison of the direct antiglobulin test and the eluate technique for diagnosing haemolytic disease of the newborn","volume":"3","author":"van Rossum","year":"2015","journal-title":"Pract Lab Med"},{"key":"10.1016\/j.tracli.2026.08.003_bib2175","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1440-1754.2010.01888.x","article-title":"Has anti-D prophylaxis increased the rate of positive direct antiglobulin test results and can the direct antiglobulin test predict need for phototherapy in Rh\/ABO incompatibility?","volume":"47","author":"Dillon","year":"2011","journal-title":"J Paediatr Child Health"},{"key":"10.1016\/j.tracli.2026.08.003_bib2180","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1177\/000992280404300108","article-title":"Readmission for newborn jaundice: the value of the Coombs\u2019 test in predicting the need for phototherapy","volume":"43","author":"Madan","year":"2004","journal-title":"Clin Pediatr (Phila)"},{"key":"10.1016\/j.tracli.2026.08.003_bib2185","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.pedneo.2014.11.005","article-title":"Importance of Direct Antiglobulin Test (DAT) in Cord Blood: causes of DAT (+) in a Cohort Study","volume":"56","author":"Valsami","year":"2015","journal-title":"Pediatr Neonatol"},{"key":"10.1016\/j.tracli.2026.08.003_bib2190","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3109\/15513815.2015.1075632","article-title":"Maternal IgG anti-A and anti-B titer levels screening in predicting ABO hemolytic disease of the newborn: a meta-analysis","volume":"34","author":"Li","year":"2015","journal-title":"Fetal Pediatr Pathol"},{"key":"10.1016\/j.tracli.2026.08.003_bib2195","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1111\/j.1651-2227.2009.01478.x","article-title":"Maternal IgG anti-A and anti-B titres predict outcome in ABO-incompatibility in the neonate","volume":"98","author":"Bakkeheim","year":"2009","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.tracli.2026.08.003_bib2200","first-page":"897","article-title":"Severe fetal hydrops resulting from ABO incompatibility","volume":"78","author":"Sherer","year":"1991","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.tracli.2026.08.003_bib2205","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1365-3148.2005.00549.x","article-title":"ABO incompatibility due to immunoglobulin G anti-B antibodies presenting with severe fetal anaemia","volume":"15","author":"Ziprin","year":"2005","journal-title":"Transfus Med"},{"key":"10.1016\/j.tracli.2026.08.003_bib2210","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/tme.12512","article-title":"Retrospective analysis of HDFN due to ABO incompatibility in a single institution over 6 years","volume":"29","author":"Matteocci","year":"2019","journal-title":"Transfus Med"},{"key":"10.1016\/j.tracli.2026.08.003_bib2215","unstructured":"D\u00e9cret no\u00a02016-46 du 26 janvier 2016 relatif \u00e0 la biologie m\u00e9dicale. Journal Officiel 0023; 2016."},{"key":"10.1016\/j.tracli.2026.08.003_bib01225","doi-asserted-by":"crossref","DOI":"10.1016\/j.tracli.2026.07.002","article-title":"Clinical input of anti-D (anti-RH1) microtitration in the management of D negative (RH:-1) pregnant women. Experience of the French National Reference Center For Perinatal Hemobiology (CNRHP)","author":"Coux","year":"2026","journal-title":"Transfus Clin Biol"}],"container-title":["Transfusion Clinique et Biologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1246782026001230?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1246782026001230?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T12:12:26Z","timestamp":1792671146000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1246782026001230"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":245,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S1246782026001230"],"URL":"https:\/\/doi.org\/10.1016\/j.tracli.2026.08.003","relation":{},"ISSN":["1246-7820"],"issn-type":[{"value":"1246-7820","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recommandations pour le suivi immuno-h\u00e9matologique (IH) de la femme enceinte. Groupe de travail\u00a0: allo-immunisation f\u0153to-maternelle anti-\u00e9rythrocytaire de la Soci\u00e9t\u00e9 francophone de transfusion sanguine","name":"articletitle","label":"Article Title"},{"value":"Transfusion Clinique et Biologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tracli.2026.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS on behalf of Soci\u00e9t\u00e9 francophone de transfusion sanguine (SFTS).","name":"copyright","label":"Copyright"}]}}